TY - JOUR
T1 - The human gut microbiome and body metabolism
T2 - Implications for obesity and diabetes
AU - Devaraj, Sridevi
AU - Hemarajata, Peera
AU - Versalovic, James
N1 - Copyright:
Copyright 2013 Elsevier B.V., All rights reserved.
PY - 2013/4
Y1 - 2013/4
N2 - Background: Obesity, metabolic syndrome, and type 2 diabetes are major public health challenges. Recently, interest has surged regarding the possible role of the intestinal microbiota as potential novel contributors to the increased prevalence of these 3 disorders. Content: Recent advances in microbial DNA sequencing technologies have resulted in the widespread application of whole-genome sequencing technologies for metagenomic DNA analysis of complex ecosystems such as the human gut. Current evidence suggests that the gut microbiota affect nutrient acquisition, energy harvest, and a myriad of host metabolic pathways. Conclusion: Advances in the Human Microbiome Project and human metagenomics research will lead the way toward a greater understanding of the importance and role of the gut microbiome in metabolic disorders such as obesity, metabolic syndrome, and diabetes.
AB - Background: Obesity, metabolic syndrome, and type 2 diabetes are major public health challenges. Recently, interest has surged regarding the possible role of the intestinal microbiota as potential novel contributors to the increased prevalence of these 3 disorders. Content: Recent advances in microbial DNA sequencing technologies have resulted in the widespread application of whole-genome sequencing technologies for metagenomic DNA analysis of complex ecosystems such as the human gut. Current evidence suggests that the gut microbiota affect nutrient acquisition, energy harvest, and a myriad of host metabolic pathways. Conclusion: Advances in the Human Microbiome Project and human metagenomics research will lead the way toward a greater understanding of the importance and role of the gut microbiome in metabolic disorders such as obesity, metabolic syndrome, and diabetes.
UR - http://www.scopus.com/inward/record.url?scp=84875826371&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84875826371&partnerID=8YFLogxK
U2 - 10.1373/clinchem.2012.187617
DO - 10.1373/clinchem.2012.187617
M3 - Review article
C2 - 23401286
AN - SCOPUS:84875826371
SN - 0009-9147
VL - 59
SP - 617
EP - 628
JO - Clinical Chemistry
JF - Clinical Chemistry
IS - 4
ER -